a. Diverticulectomy and myotomy b. Myotomy alone c. Diverticulectomy alone
PerOral Endoscopic Myotomy for Motility Disorders and GISTs · 2017-12-29 · PerOral Endoscopic...
Transcript of PerOral Endoscopic Myotomy for Motility Disorders and GISTs · 2017-12-29 · PerOral Endoscopic...
PerOral Endoscopic Myotomy for Motility Disorders and GISTs
Steven R. DeMeesterThoracic and Foregut Surgery
The Oregon Clinic
POEM• First human procedure in 2008 with Dr. Haruhiro
Inoue in Japan (who had previously introduced endoscopic mucosal resection)
• Concept based on animal work by Dr. Pasrichafrom one year earlier at Hopkins
• First publication of results in 17 patients by Dr. Inoue in 2010
POEM
• By 2011 first reports coming from USA and shortly after Europe and China
• To date an estimated 10,000 or more procedures have been performed, and indications have expanded to include failed prior therapies for achalasia, other motility abnormalities in the esophagus, cricopharyngeous and pylorus, and for intramural tumors of the esophagus and stomach
JACS
Concept of POEM
• Inject to lift submucosa• Create mucosotomy• Develop submucosal tunnel• Extend tunnel 2-3 cm distal to GEJ• Perform myotomy• Close mucosotomy
Concept of POEM
Confirm Tunnel is 2-3 cm Distal to the GEJ
Perform Myotomy
Close Mucosotomy
Outcome with POEM• 500 consecutive patients, achalasia types I,
II and III• Included redo procedures and sigmoid
esophagus• Median operative time 90 minutes• Complications in 3.2%, no conversions• Overall success rate at 1-2 years after
POEM was 91%, 89% at 3 years• Heartburn symptoms in 21% with
endoscopic esophagitis in 56%Inoue H, et al. J Am Coll Surg, 2015
500 Consecutive POEM Procedures: Outcome
Inoue H, et al. J Am Coll Surg, 2015
5-yr and Longer Follow-up after POEM• 27 patients that had POEM in Portland prior to
February 2012• Symptomatic success at 5 years was 83%• Significant continued reduction in Eckardt
score (6.4 pre-POEM vs 1.7 current; p<0.001)• No patients required re-intervention during the
5 years of follow-up• EGD at 5 years in 16 patients showed
esophagitis in 2 (13%) and Barrett’s without dysplasia in one patient
Teitelbaum EN, et al. SAGES, 2017
5+ Year Outcomes after POEMPreop baseline 5 years postop
Eckardt score (range 0 – 12) 6.2 ± 2.6 1.7 ± 1.6*
Dysphagia (range 0 – 3) 2.4 ± 0.8 0.9 ± 1*
Regurgitation (range 0 – 3) 1.4 ± 1.1 0.3 ± 0.5*
Chest pain (range 0 – 3) 0.8 ± 1.1 0.5 ± 0.8*
Weight loss (range 0 – 3) 1.6 ± 1.4 0 ± 0*
*: p-value < 0.001
Teitelbaum EN, et al. SAGES, 2017
POEM: What We Have Learned• Safe with a low complication rate• Provides long-term, sustained dysphagia relief
equivalent to other achalasia therapies including Heller myotomy
• More reflux symptoms and esophagitis compared to other therapies, but all therapies associated with GERD potential• Avoid POEM in patients with hiatal hernia or
complications of GERD such as Barrett’s esophagus at the time of diagnosis of achalasia
• Long-term follow-up including EGD essential in all achalasia patients after therapy
POEM Concepts Extended
• Zenker’s and cricopharyngeal dysfunction
• Gastroparesis for pyloroplasty
• Endoscopic resection of gastric and esophageal intramural lesions (leimyomaand GIST)
Endoscopic Leiomyoma Resection
Endoscopic Leiomyoma Resection
Gastric GIST Resections
Endoscopic GIST Resection• Ability to perform procedure well demonstrated,
infrequent conversions• Mixture of endoscopic enucleation and
endoscopic full thickness resection techniques• Minimal complications• Ideal for tumors at GEJ and in esophagus• Long-term outcome uncertain (limited follow-up
typically under 2 years
Li QT, et al. Gastrointest Endosc, 2012He Z, et al. J Gastro Hepatol, 2013Jeong H, et al. Surg Lap Endo Perc Tech, 2012Andalib I, et al. Surg Endosc, 2017
Li QT, et al.Gastrointest Endosc,2012
Lap vs Endoscopic GIST Resection
Jeong H, et al. Surg Lap Endo Perc Tech, 2012
Lap vs Endoscopic GIST Resection
Jeong H, et al. Surg Lap Endo Perc Tech, 2012
Conclusions• POEM and endoscopic resection techniques are
here to stay, and offer advantages over other minimally invasive procedures including laparoscopy and VATS for a variety of foregut motility disorders and benign to low-grade malignant intramural tumors
• Safety, recovery and efficacy data thus far makes endoscopic approaches appealing to patients
• Thoracic surgeons need to be on the forefront of these techniques to maintain a leading role in the management of foregut disease